Literature DB >> 17537432

Stress-induced hyperthermia: effects of acute and repeated dosing of MPEP.

Rebecca E Nordquist1, Sean Durkin, Georg Jaeschke, Will Spooren.   

Abstract

The mGlu5 receptor antagonist 2-methyl-6-(phenylethylnyl)-pyridine (MPEP) is highly anxiolytic in rodent models of anxiety. Recent studies showed that MPEP remains effective in some models of anxiety after repeated treatment, but tolerance may develop in other models. To further evaluate anxiolytic properties of repeated MPEP, a single administration of 3, 10, or 30 mg/kg p.o. and repeated administration of 30 mg/kg p.o. was tested in the stress-induced hyperthermia model in mice. MPEP dose-dependently inhibited stress-induced hyperthermia when given acutely. MPEP remained equally active in reducing stress-induced hyperthermia after five daily treatments with 30 mg/kg, further validating MPEP as a potential anxiolytic for chronic use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537432     DOI: 10.1016/j.ejphar.2007.04.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

Authors:  John H Krystal; Sanjay J Mathew; D Cyril D'Souza; Amir Garakani; Handan Gunduz-Bruce; Dennis S Charney
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

2.  Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.

Authors:  Justin T Gass; M Foster Olive
Journal:  Eur J Pharmacol       Date:  2008-02-20       Impact factor: 4.432

3.  Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism.

Authors:  Jill L Silverman; Brooke A Babineau; Chicora F Oliver; Michael N Karras; Jacqueline N Crawley
Journal:  Neuropharmacology       Date:  2012-08-08       Impact factor: 5.250

4.  Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine.

Authors:  Donna M Platt; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-05-29       Impact factor: 4.530

Review 5.  Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.

Authors:  R E Nordquist; T Steckler; J G Wettstein; C Mackie; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-06       Impact factor: 4.530

6.  Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.

Authors:  Jill L Silverman; Seda S Tolu; Charlotte L Barkan; Jacqueline N Crawley
Journal:  Neuropsychopharmacology       Date:  2009-12-23       Impact factor: 7.853

Review 7.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

8.  Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism.

Authors:  Sarah N Isherwood; Anton Pekcec; Janet R Nicholson; Trevor W Robbins; Jeffrey W Dalley
Journal:  Psychopharmacology (Berl)       Date:  2015-06-12       Impact factor: 4.530

9.  Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice.

Authors:  Amber R Salomons; Nathaly Espitia Pinzon; Hetty Boleij; Susanne Kirchhoff; Saskia S Arndt; Rebecca E Nordquist; Lothar Lindemann; Georg Jaeschke; Will Spooren; Frauke Ohl
Journal:  Behav Brain Funct       Date:  2012-06-11       Impact factor: 3.759

10.  Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes.

Authors:  Christiaan H Vinkers; Hendrikus Hendriksen; Ruud van Oorschot; James M Cook; Sundari Rallipalli; Shengming Huang; Mark J Millan; Berend Olivier; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.